Orbimed Advisors - XENOPORT INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of XENOPORT INC
ValueSharesWeighting
Q1 2016$27,062,000
-14.5%
6,000,400
+4.0%
0.28%
-0.7%
Q4 2015$31,669,000
+58.2%
5,768,4000.0%0.29%
+42.1%
Q3 2015$20,016,000
-43.4%
5,768,4000.0%0.20%
-22.0%
Q2 2015$35,360,000
-10.5%
5,768,400
+4.0%
0.26%
-23.1%
Q1 2015$39,488,000
-18.8%
5,546,1000.0%0.34%
-27.5%
Q4 2014$48,639,000
+63.0%
5,546,1000.0%0.46%
+49.0%
Q3 2014$29,838,000
+11.4%
5,546,1000.0%0.31%
-1.0%
Q2 2014$26,788,000
-6.6%
5,546,1000.0%0.32%
-10.8%
Q1 2014$28,673,000
+8.6%
5,546,100
+20.8%
0.35%
-9.0%
Q4 2013$26,397,000
+10.1%
4,590,800
+8.7%
0.39%
-9.3%
Q3 2013$23,984,000
+19.9%
4,222,600
+4.5%
0.43%
+0.9%
Q2 2013$20,002,0004,040,8000.42%
Other shareholders
XENOPORT INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,600,000$9,808,0003.52%
DAFNA Capital Management LLC 531,032$3,255,0002.75%
SENZAR ASSET MANAGEMENT, LLC 1,722,100$10,556,0001.81%
GREAT POINT PARTNERS LLC 485,000$2,973,0001.16%
Opus Point Partners Management, LLC 130,000$797,0000.63%
Kazazian Asset Management, LLC 65,022$399,0000.39%
Baker Brothers Advisors 6,508,622$39,898,0000.35%
Orbimed Advisors 5,768,400$35,360,0000.26%
CORRADO ADVISORS, LLC 74,500$457,0000.21%
NJ State Employees Deferred Compensation Plan 130,000$797,0000.16%
View complete list of XENOPORT INC shareholders